Literature DB >> 8698432

Comparison of changes in cardiac structure after treatment in secondary hypertension.

Y Yoshitomi1, T Nishikimi, H Abe, F Yoshiwara, T Suzuki, A Ashizawa, S Nagata, M Kuramochi, H Matsuoka, T Omae.   

Abstract

To investigate the role of aldosterone and the renin-angiotensin system in cardiac structure, we performed echocardiography in patients with secondary hypertension. The relation between blood pressure or hormonal influences and left ventricular hypertrophy has not been well established in secondary hypertension. Sixteen patients with primary aldosteronism and 11 with unilateral renovascular hypertension who had completely normalized blood pressure after operation or percutaneous transluminal angioplasty were evaluated by echocardiography before and after surgery or other interventional treatment. Blood pressure was not statistically different between the groups before treatment and was normalized after treatment in both groups. Left ventricular hypertrophy was mild in both groups before treatment, and its degree was not statistically different between the groups. At the end of the follow-up period, all parameters of primary aldosteronism and left ventricular mass index in patients with unilateral renovascular hypertension were significantly reduced. In patients with primary aldosteronism, changes in end-diastolic left ventricular internal dimension correlated positively with changes in left ventricular mass index (r=.58,P<.01). In patients with unilateral renovascular hypertension, changes in mean blood pressure and left ventricular mass index were significantly correlated (r=.77,P<.01). The expanded plasma volume induced by an excess of aldosterone and high blood pressure may play an important role in the increase of left ventricular mass in primary aldosteronism. In unilateral renovascular hypertension, high blood pressure mainly contributes significantly to increased left ventricular mass. Therefore, different factors may modulate the development of left ventricular hypertrophy in patients with secondary hypertension.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8698432     DOI: 10.1161/01.hyp.27.3.319

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  5 in total

Review 1.  Left ventricular remodeling and dysfunction in primary aldosteronism.

Authors:  Cheng-Hsuan Tsai; Chien-Ting Pan; Yi-Yao Chang; Zheng-Wei Chen; Vin-Cent Wu; Chi-Sheng Hung; Yen-Hung Lin
Journal:  J Hum Hypertens       Date:  2020-10-16       Impact factor: 3.012

2.  Aldosterone induced galectin-3 secretion in vitro and in vivo: from cells to humans.

Authors:  Yen-Hung Lin; Chia-Hung Chou; Xue-Ming Wu; Yi-Yao Chang; Chi-Sheng Hung; Ying-Hsien Chen; Yu-Lin Tzeng; Vin-Cent Wu; Yi-Lwun Ho; Fon-Jou Hsieh; Kwan-Dun Wu
Journal:  PLoS One       Date:  2014-09-02       Impact factor: 3.240

3.  Cardiac structure and function after revascularization versus medical therapy for renal artery stenosis: the ASTRAL heart echocardiographic sub-study.

Authors:  Darren Green; Diana Vassallo; Kelly Handley; Natalie Ives; Keith Wheatley; Constantina Chrysochou; Janet Hegarty; Julian Wright; Jon Moss; Rajan K Patel; Chris Deighan; John Webster; Peter Rowe; Sue Carr; Jenny Cross; Jamie O'Driscoll; Raj Sharma; Patrick Mark; Philip A Kalra
Journal:  BMC Nephrol       Date:  2019-06-14       Impact factor: 2.388

4.  Incidental Congestive Heart Failure in Patients With Aldosterone-Producing Adenomas.

Authors:  Wei-Chieh Huang; Ying-Ying Chen; Yen-Hung Lin; Likwang Chen; Po-Chih Lin; Yu-Feng Lin; Yu-Chun Liu; Che-Hsiung Wu; Jeff S Chueh; Tzong-Shinn Chu; Kwan Dun Wu; Chun-Yao Huang; Vin-Cent Wu
Journal:  J Am Heart Assoc       Date:  2019-12-05       Impact factor: 5.501

5.  Left Ventricular Dysfunction in Patients With Primary Aldosteronism: A Propensity Score-Matching Follow-Up Study With Tissue Doppler Imaging.

Authors:  Yi-Yao Chang; Che-Wei Liao; Cheng-Hsuan Tsai; Ching-Way Chen; Chien-Ting Pan; Zheng-Wei Chen; Ya-Li Chen; Lung-Chun Lin; Yi-Ru Chang; Vin-Cent Wu; Kwan-Dun Wu; Chi-Sheng Hung; Yen-Hung Lin
Journal:  J Am Heart Assoc       Date:  2019-11-13       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.